Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

ARCA biopharma Q2 EPS $(0.22) Up From $(0.34) YoY

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.22) per share. This is a 35.29 percent increase over losses of $(0.34) per share from the same period last year.
byBenzinga Newsdesk
August 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.22) per share. This is a 35.29 percent increase over losses of $(0.34) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With EV-Maker Canoo’s Stock?

By Erica Kollmann
April 17, 3:45 PM
Benchmark analyst Michael Legg initiated coverage on Canoo with a Buy rating and a price target of $5 Wednesday. Legg highlighted the company's pipeline which features $750 million in contracted orders with clients including Walmart Inc., the United States Postal Service and the U.S. military. The analyst said that the market appears to have "lost sight of the magnitude of the opportunity" in Canoo.

GOEV